In light of a recent study on semaglutide for alcohol cravings, and ever-increasing use of this peptide, today Ill be breaking down what the latest research shows on this topic, what it might mean, and of course, my functional medicine perspective on semaglutide, GLP-1, gut health, and alcohol
Explores recommendations for how often individuals on GLP-1 medications should undergo DEXA scans to monitor changes in body composition effectively
FAQ: Q1: Are you trading company or manufacturer
Carnitine is the carrier molecule that moves long-chain fatty acids across the mitochondrial membrane for beta-oxidation
T2DM is often accompanied with islet fibrosis in both animal models and patients [4, 5]
The published SURMOUNT-1 data in adults without diabetes over 72 weeks, per Eli Lilly's disclosed trial information: 5mg dose: average weight loss of 15.0% of body weight (approximately 34 lbs) 10mg dose: average weight loss of 19.5% of body weight (approximately 44 lbs) 15mg dose: average weight loss of 20.9% of body weight (approximately 48 lbs) Placebo: average weight loss of 3.1% (approximately 7 lbs) Average starting weights ranged from 226.8 to 233.3 lbs across dose groups
